| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.01 | 0.9 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.9 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | -0.0051 | 0.9 |